Akumentis Healthcare launches Clasepi, synthetic CBD for epilepsy EP News Bureau Jan 10, 2024 Clasepi comes with important usage considerations; it is not recommended for individuals allergic to cannabidiol or any of its…
US FDA grants approval of Fintepla to Zogenix EP News Bureau Jun 26, 2020 Fintepla offers an additional effective treatment option for the treatment of seizures associated with Dravet syndrome: Zogenix
